New York, NY (PRWEB) April 15, 2013
Are “stem cell facelifts” and “stem cell breast augmentation” better than traditional procedures? Although stem cell therapy may be promising for a variety of medical conditions, the jury is still out on whether stem cell-based treatments are of benefit in aesthetic medicine. A panel at the Annual Meeting of the American Society for Aesthetic Plastic Surgery (ASAPS), being held April 11-16, 2013, in New York, NY, will examine stem cell claims in plastic surgery and discuss the latest findings from this much-hyped field. “Stem Cell Hysteria – Do Stem Cells Make a Difference? Do They Affect Clinical Outcomes?” will be moderated by Robert Singer, MD, and feature panelists Sydney Coleman, MD, John Hijjawi, MD, Daniel A. Del Vecchio, MD, and J. Peter Rubin, MD. While stem cells are being studied for the treatment of a variety of medical conditions, this panel focuses specifically on the role of stem cells in cosmetic procedures.
“There is a lot of marketing hype about the role of stem cells in aesthetic procedures,” said Dr. Singer of La Jolla, CA. “We are hopeful that this is the next frontier, but, unfortunately, there is no current scientific evidence that stem cells improve aesthetic outcomes.”
“This panel is critical because “stem cells” is such a hot term, used to market everything from surgical procedures to over-the-counter facial creams,” added Dr. Hijjawi of Milwaukee, WI. “As ASAPS members, we are concerned about all of the amazing claims being made about stem cells, and about finding out what the truth behind the claims really is.”
Research is currently ongoing to define the potential role of stem cells in aesthetic surgery, particularly for stem cells derived from the fat tissue. Each of the presenters on the panel is actively engaged in clinical or basic science research looking at stem cell therapy, including its impact on fat grafting outcomes in aesthetic
Copyright©2012 Vocus, Inc.
All rights reserved